The Company remains actively engaged in discussions with the U.S. Federal Trade Commission (“FTC”) on the FTC’s continued review of the proposed transaction. To allow the transaction to close on a …

More Bristol-Myers Squibb Provides Update on Pending Merger with Celgene Videos